581 related articles for article (PubMed ID: 8882597)
1. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
[TBL] [Abstract][Full Text] [Related]
2. Action of picolinic acid and structurally related pyridine carboxylic acids on quinolinic acid-induced cortical cholinergic damage.
Cockhill J; Jhamandas K; Boegman RJ; Beninger RJ
Brain Res; 1992 Dec; 599(1):57-63. PubMed ID: 1493549
[TBL] [Abstract][Full Text] [Related]
3. The neurotoxic actions of quinolinic acid in the central nervous system.
el-Defrawy SR; Boegman RJ; Jhamandas K; Beninger RJ
Can J Physiol Pharmacol; 1986 Mar; 64(3):369-75. PubMed ID: 2939936
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
5. 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum.
Guidetti P; Schwarcz R
Eur J Neurosci; 1999 Nov; 11(11):3857-63. PubMed ID: 10583474
[TBL] [Abstract][Full Text] [Related]
6. Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites.
Jhamandas K; Boegman RJ; Beninger RJ; Bialik M
Brain Res; 1990 Oct; 529(1-2):185-91. PubMed ID: 2149296
[TBL] [Abstract][Full Text] [Related]
7. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
8. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
9. Ferrous iron modulates quinolinate-mediated [3H]MK-801 binding to rat brain synaptic membranes in the presence of glycine and spermidine.
St'astny F; Hinoi E; Ogita K; Yoneda Y
Neurosci Lett; 1999 Mar; 262(2):105-8. PubMed ID: 10203242
[TBL] [Abstract][Full Text] [Related]
10. The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists.
Jhamandas KH; Boegman RJ; Beninger RJ
Can J Physiol Pharmacol; 1994 Dec; 72(12):1473-82. PubMed ID: 7736338
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
Zhang XX; Bunney BS; Shi WX
Synapse; 2000 Jul; 37(1):56-63. PubMed ID: 10842351
[TBL] [Abstract][Full Text] [Related]
12. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
Zhong J; Gribkoff VK; Molinoff PB
Mol Pharmacol; 1996 Sep; 50(3):631-8. PubMed ID: 8794904
[TBL] [Abstract][Full Text] [Related]
13. Quinolinate potentiates the neurotoxicity of excitatory amino acids in hypoxic neuronal tissue in vitro.
Schurr A; Rigor BM
Brain Res; 1993 Jul; 617(1):76-80. PubMed ID: 8397046
[TBL] [Abstract][Full Text] [Related]
14. 7-Chlorokynurenate prevents NMDA-induced and kainate-induced striatal lesions.
Lehmann JC; Procureur D; Wood PL
Brain Res; 1993 Aug; 620(1):1-6. PubMed ID: 7691379
[TBL] [Abstract][Full Text] [Related]
15. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum.
Bazzett TJ; Falik RC; Becker JB; Albin RL
Brain Res; 1996 Apr; 718(1-2):228-32. PubMed ID: 8773793
[TBL] [Abstract][Full Text] [Related]
17. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
18. NMDA antagonist blockade of AT8 tau immunoreactive changes in neuronal cultures.
Couratier P; Lesort M; Terro F; Dussartre C; Hugon J
Fundam Clin Pharmacol; 1996; 10(4):344-9. PubMed ID: 8871133
[TBL] [Abstract][Full Text] [Related]
19. Chronic dosing with 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, modulates NMDA inhibition of muscarinic-coupled PI hydrolysis in rat cortical slices.
Boje KM; Lakhman SS
Neurochem Res; 1998 Sep; 23(9):1167-74. PubMed ID: 9712186
[TBL] [Abstract][Full Text] [Related]
20. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
